Liminatus Pharma Inc. Class A Common Stock (LIMN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Liminatus Pharma Inc. Cla...

    NASDAQ: LIMN · Real-Time Price · USD
    1.67
    0.22 (15.17%)
    At close: Sep 29, 2025, 3:59 PM
    1.66
    -0.59%
    After-hours: Sep 29, 2025, 07:48 PM EDT

    Liminatus Pharma Class A Common Stock Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -2.91M -2.59M -2.71M -2.53M
    Interest Income
    		 137.72K 10K n/a 16.84K
    Pretax Income
    		 -2.89M -1.19M -2.93M 4.37M
    Net Income
    		 -2.9M -4.98M -2.93M 4.37M
    Selling & General & Admin
    		 2.91M 1.06M 856K 2.53M
    Research & Development
    		 n/a 3.76M 1.85M n/a
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 2.91M 4.82M 2.71M 2.53M
    Interest Expense
    		 138.1K 175K 219K n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 2.91M 4.82M 2.71M 2.53M
    Income Tax Expense
    		 18.84K 33.99K n/a n/a
    Shares Outstanding (Basic)
    		 7.19M 8.01M 34.43M 34.5M
    Shares Outstanding (Diluted)
    		 7.19M 8.01M 34.43M 34.5M
    EPS (Basic)
    		 -0.4 -0.15 0.30 0.13
    EPS (Diluted)
    		 -0.4 -0.15 0.30 0.13
    EBITDA
    		 -2.75M -4.81M -2.71M 4.37M
    EBIT
    		 -2.75M -4.81M -2.71M 4.37M
    Depreciation & Amortization
    		 n/a n/a n/a n/a

    Add to Watchlist